Antiverse


Programme

Accelerate Plus

Sector

Healthcare/Pharma/Biotech



Programme
Accelerate Plus (Cohort 15)
Founded in
2017
Total funds raised
£5.3 million
Employees
11-50
Industry
Pharmaceutical

Co-founded in 2017, our team is dedicated to engineering the future of drug discovery to change the course of people’s lives. We are passionate about what we do and the impact our discoveries have on patients across the globe.

Based in Cardiff, our expert team spans structural biology, machine learning and medicine – and together, we are striving for that next breakthrough in drug discovery. Antiverse is a new type of antibody discovery company accelerating drug development. Its platform exists at the intersection of structural biology, machine learning, and medicine to enable breakthroughs to happen more quickly and cost-effectively. It is dedicated to engineering the future of drug development to change the course of people’s lives.

Get in touch

Visit Antiverse's website

Email [email protected]

Follow Antiverse on LinkedIn

See all Accelerate Cambridge ventures

Top